View all news

    U.S. FDA Approves DARZALEX® (daratumumab) Split-Dosing Regimen

    02/12/2019
    Download(opens in new window)PDF 186 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com